A detailed history of Dimensional Fund Advisors LP transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 39,606 shares of SERA stock, worth $323,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,606
Previous 45,431 12.82%
Holding current value
$323,977
Previous $268,000 14.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$5.29 - $8.43 $30,814 - $49,104
-5,825 Reduced 12.82%
39,606 $308,000
Q2 2024

Aug 09, 2024

BUY
$5.6 - $11.69 $5,146 - $10,743
919 Added 2.06%
45,431 $268,000
Q1 2024

May 10, 2024

BUY
$5.05 - $10.0 $149,141 - $295,330
29,533 Added 197.16%
44,512 $405,000
Q3 2023

Nov 09, 2023

SELL
$1.55 - $3.34 $7,660 - $16,506
-4,942 Reduced 24.81%
14,979 $27,000
Q1 2023

May 12, 2023

BUY
$1.19 - $4.25 $23,705 - $84,664
19,921 New
19,921 $76,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $242M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.